Comparing two surgical methods for pancreatic cancer treatment
Official title: Total Laparoscopic Pancreaticoduodenectomy Versus Open Pancreaticoduodenectomy for Pancreatic Carcinoma(TJDBPS07) a Multicenter Randomized Controlled Trial
Run by Tongji Hospital · NCT03785743 · Data updated 2026-11-12
This study is testing if a less invasive surgery for pancreatic cancer works better than traditional surgery in helping patients live longer after treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | March 1, 2019 |
| Main results expected | March 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | March 2, 2022 |
| Trial ID | NCT03785743 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 75 with histologically confirmed or clinically diagnosed pancreatic ductal adenocarcinoma who are eligible for both surgical techniques.
✕Probably not a fit
Patients with distant metastases, severe comorbidities, or those requiring palliative surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of total laparoscopic pancreaticoduodenectomy (TLPD) versus open pancreaticoduodenectomy (OPD) in patients with pancreatic carcinoma. It is a multicenter, prospective, randomized controlled trial involving 200 patients who will be allocated to either surgical group. The study focuses on evaluating overall survival rates while implementing an enhanced recovery after surgery (ERAS) protocol. The trial addresses the ongoing debate regarding the superiority of minimally invasive surgery compared to traditional open surgery for this aggressive cancer.
Why it matters
Potential benefit: If successful, this study could provide insights into which surgical approach offers better survival outcomes for patients with pancreatic cancer.
How similar studies have gone: While studies comparing laparoscopic and open surgery exist, this trial is significant as it is a randomized controlled trial specifically designed to address the lack of robust evidence in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 years and 75 years. 2. Histologically confirmed PDAC or clinically diagnosed PDAC by an MDT without histopathologic evidence. 3. Patients feasible to undergo both LPD and OPD according to MDT evaluations. 4. Patients understanding and willing to comply with this trial. 5. Provision of written informed consent before patient registration. 6. Patients meeting the curative treatment intent in accordance with clinical guidelines. Exclusion Criteria: 1. Patients with distant metastases, including peritoneal, liver, distant lymph node metastases, and involvement of other organs. 2. Patients requiring left, central or total pancreatectomy or other palliative surgery. 3. Preoperative American Society of Anaesthesiologists (ASA) score ≥ 4. 4. History of other malignant disease. 5. Pregnant or breast-feeding women. 6. Patients with serious mental disorders. 7. Patients treated with neoadjuvant therapy. 8. Patients with vascular invasion and requiring vascular resection as evaluated by the MDT team according to abdominal imaging data. 9. Body mass index \> 35 kg/m2. 10. Patients participating in any other clinical trials within 3 months.
Where it's running
-
Department of Biliary and Pancreatic Surgery, Tongji Hospital, Affiliated Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China Recruiting
Study contacts
- Principal investigator: Renyi Qin — Tongji Hospital
- Study coordinator: Renyi Qin
- Email: 172356995@qq.com
- Phone: +8602783665314
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Energy needs after pancreatic surgery: measuring metabolism to guide nutrition
This study tests how much energy patients need after pancreatic surgery and compares direct measurements with common estimating methods to see if standard formulas are accurate.
-
Laparoscopy vs Open Surgery for Endometrial Cancer Staging in Low-Resource Settings
This study tests whether laparoscopic surgical staging for early endometrial cancer leads to faster first ambulation compared with open surgery in low-resource settings.
-
Short preoperative stereotactic radiotherapy to prevent pancreatic leaks after Whipple surgery
This trial will test whether a short course of stereotactic radiotherapy given before a Whipple operation can reduce the chance of a pancreatic leak (fistula) in adults having a pancreaticoduodenectomy.
-
Laryngopharyngeal injuries after breathing tube placement during general anesthesia
This project sees how often and why people who had a breathing tube during general anesthesia developed hoarseness or other throat problems after non-ear–nose–throat surgery.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Tissue-glue injection into the pancreas during pancreaticoduodenectomy
This trial will test whether injecting a tissue glue called N-butyl-2-cyanoacrylate into the pancreatic remnant during pancreaticoduodenectomy reduces postoperative pancreatic fistulas in patients with a soft pancreas and a small main duct.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.